General Information of Drug (ID: DMUY53P)

Drug Name
PMID29671355-Compound-18
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 320.3
Logarithm of the Partition Coefficient (xlogp) 2.4
Rotatable Bond Count (rotbonds) 5
Hydrogen Bond Donor Count (hbonddonor) 2
Hydrogen Bond Acceptor Count (hbondacc) 5
Chemical Identifiers
Formula
C18H16N4O2
IUPAC Name
4-[(dipyridin-2-ylamino)methyl]-N-hydroxybenzamide
Canonical SMILES
C1=CC=NC(=C1)N(CC2=CC=C(C=C2)C(=O)NO)C3=CC=CC=N3
InChI
InChI=1S/C18H16N4O2/c23-18(21-24)15-9-7-14(8-10-15)13-22(16-5-1-3-11-19-16)17-6-2-4-12-20-17/h1-12,24H,13H2,(H,21,23)
InChIKey
FWQCLQYFYHSYHY-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
86302675
TTD ID
D0TN6E

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Histone deacetylase 1 (HDAC1) TT6R7JZ HDAC1_HUMAN Inhibitor [1]
Histone deacetylase 6 (HDAC6) TT5ZKDI HDAC6_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Histone deacetylase 1 (HDAC1) DTT HDAC1 1.54E-06 0.66 4.44
Histone deacetylase 6 (HDAC6) DTT HDAC6 6.91E-02 0.27 0.79
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 HDAC inhibitors: a 2013-2017 patent survey.Expert Opin Ther Pat. 2018 Apr 19:1-17.